Skip to content

Biodex Act-O-Kit Tsh-Ria-

by Biodan Medical Systems, Ltd.

510(k) K840088

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK840088 Date7 May 1984ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
JLW
Device Class
Class II
Regulation
21 CFR Part 862.1690
Advisory Committee
Clinical Chemistry
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The BIODEX ACT-O-KIT TSH-RIA is a radioimmunoassay kit designed for the quantitative measurement of thyroid-stimulating hormone (TSH) in clinical samples. As classified under the nomenclature for radioimmunoassay devices, it employs immunochemical techniques to detect and quantify TSH levels, aiding in the diagnosis and monitoring of thyroid disorders. The device operates within the domain of clinical chemistry, providing precise analytical results for laboratory use.

This kit is supplied as a single-use diagnostic reagent intended for in vitro laboratory settings. It requires no special sterility beyond standard aseptic handling procedures for immunoassay reagents. The device is not MRI-compatible, and no specific size or storage conditions are noted beyond typical laboratory storage for immunoassay kits. Authorized for commercial distribution in the United States under an FDA 510(k) clearance (K840088), the kit falls under the regulatory classification of Class II medical devices, with a decision of Substantially Equivalent (SESE) to a predicate device.

Other devices from Biodan Medical Systems, Ltd.

See all devices from Biodan Medical Systems, Ltd. →

Questions

AI-generated answers, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the BIODEX ACT-O-KIT TSH-RIA used for?

    The BIODEX ACT-O-KIT TSH-RIA is designed for the quantitative measurement of thyroid-stimulating hormone (TSH) in clinical samples. It employs radioimmunoassay techniques to detect and quantify TSH levels, which aids in diagnosing and monitoring thyroid disorders such as hypothyroidism or hyperthyroidism. This precise analytical tool is intended for use in in vitro laboratory settings to support clinical chemistry assessments.

  • How is the BIODEX ACT-O-KIT TSH-RIA supplied and what are its sterility requirements?

    The kit is supplied as a single-use diagnostic reagent intended exclusively for in vitro laboratory use. Standard aseptic handling procedures for immunoassay reagents are sufficient—no additional sterility measures are specified beyond typical laboratory practices. This ensures safe and controlled use while maintaining the integrity of the assay components.

  • Is the BIODEX ACT-O-KIT TSH-RIA reusable or single-use?

    The BIODEX ACT-O-KIT TSH-RIA is explicitly designed for single-use only. This design choice minimizes cross-contamination risks and ensures consistent, reliable results for each assay. Reuse is not recommended or supported by the manufacturer, as it could compromise the accuracy and validity of the test.

  • Are there specific storage conditions for the BIODEX ACT-O-KIT TSH-RIA?

    The kit does not specify unusual storage conditions beyond what is standard for immunoassay reagents in a laboratory setting. It should be stored under typical laboratory conditions—protected from extreme temperatures, light, and moisture—to preserve its performance and accuracy. Always follow manufacturer guidelines for optimal shelf life and usability.

  • What regulatory pathway does the BIODEX ACT-O-KIT TSH-RIA follow?

    The BIODEX ACT-O-KIT TSH-RIA is authorized for commercial distribution in the United States under an FDA 510(k) clearance (K840088). It falls under the regulatory classification of Class II medical devices, with a decision of Substantially Equivalent (SESE) to a predicate device. This clearance confirms that the device meets FDA standards for safety and effectiveness as a radioimmunoassay kit for TSH measurement.